12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 88.9% to $0.39 during Tuesday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Akanda (NASDAQ:AKAN) shares rose 177.7% to $0.37 during Friday’s pre-market session. The company’s market cap stands at…
Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by around 0.1% on Thursday. When insiders purchase or sell shares, it…
What’s Going On With Reneo Pharmaceuticals Stock Today?
Reneo and Onkure announced Monday that they have entered into a definitive merger agreement to combine the two companies in an all-stock transaction.
Reneo Pharmaceuticals: Q4 Earnings Insights
Reneo Pharmaceuticals (NASDAQ:RPHM) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:35 AM. Here’s what…
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.
Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal.
Ascent Industries shares surged 7.4% to $8.69 in pre-market trading.
Reneo Pharmaceuticals Inc Says On Dec 26, Concentra, An Affiliate Of Tang Capital Partners, Sent Acquisition Proposal To The Co; On Behalf Of Concentra Biosciences, Submit Non-Binding Proposal To Acquire 100% Of Equity Of Reneo For $1.80 Per Share
Concentra Biosciences, LLC4747 Executive Drive, Suite 210 | San Diego, CA 92121December 26, 2023Board of DirectorsReneo Pharmaceuticals, Inc.c/o Gregory J. Flesher, President and Chief Executive Officer18575
5 Analysts Have This to Say About Reneo Pharmaceuticals
Within the last quarter, Reneo Pharmaceuticals (NASDAQ:RPHM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Crude Oil Rises Sharply; Adobe Shares Fall
U.S. stocks traded higher midway through trading, following the release of economic reports on Thursday.
The Dow traded up 0.44% to 37,254.25 while the NASDAQ rose 0.42% to 14,795.52. The S&P 500 also rose, gaining, 0.54% to 4,732.70.